Combination of oncolytic adenovirus and dacarbazine enhances antitumor ability against uveal melanoma cells via cell cycle block

References

• van den Bosch T, Kilic E, Paridaens D, de Klein A. Genetics of uveal melanoma and cutaneous melanoma: two of a kind?. Dermatol Res Pract 2010; In press http://dx.doi.org/10.1155/2010/360136; PMID: 20631901
   PubMedGoogle Scholar
• Singh AD, Borden EC. Metastatic uveal melanoma. Ophthalmol Clin North Am 2005; 18:143 - 50; http://dx.doi.org/10.1016/j.ohc.2004.07.003; PMID: 15763199
   PubMedGoogle Scholar
• Shields CL, Shields JA. Ocular melanoma: relatively rare but requiring respect. Clin Dermatol 2009; 27:122 - 33; http://dx.doi.org/10.1016/j.clindermatol.2008.09.010; PMID: 19095158
   PubMed Web of Science ®Google Scholar
• Coupland SE, Anastassiou G, Stang A, Schilling H, Anagnostopoulos I, Bornfeld N, et al. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma. J Pathol 2000; 191:120 - 6; http://dx.doi.org/10.1002/(SICI)1096-9896(200006)191:2<120::AID-PATH591>3.0.CO;2-P; PMID: 10861569
   PubMed Web of Science ®Google Scholar
• Quirin C, Mainka A, Hesse A, Nettelbeck DM. Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cells. Int J Cancer 2007; 121:2801 - 7; http://dx.doi.org/10.1002/ijc.23052; PMID: 17724714
   PubMed Web of Science ®Google Scholar
• Lillehammer T, Engesaeter BO, Prasmickaite L, Maelandsmo GM, Fodstad O, Engebraaten O. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines. J Gene Med 2007; 9:440 - 51; http://dx.doi.org/10.1002/jgm.1036; PMID: 17410615
   PubMed Web of Science ®Google Scholar
• Bajetta E, Del Vecchio M, Bernard-Marty C, Vitali M, Buzzoni R, Rixe O, et al. Metastatic melanoma: chemotherapy. Semin Oncol 2002; 29:427 - 45; http://dx.doi.org/10.1053/sonc.2002.35238; PMID: 12407508
   PubMed Web of Science ®Google Scholar
• Bagnyukova TV, Serebriiskii IG, Zhou Y, Hopper-Borge EA, Golemis EA, Astsaturov I. Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?. Cancer Biol Ther 2010; 10:839 - 53; http://dx.doi.org/10.4161/cbt.10.9.13738; PMID: 20935499
   PubMed Web of Science ®Google Scholar
• Yu W, Fang H. Clinical trials with oncolytic adenovirus in China. Curr Cancer Drug Targets 2007; 7:141 - 8; http://dx.doi.org/10.2174/156800907780058817; PMID: 17346105
   PubMed Web of Science ®Google Scholar
• Song X, Zhou Y, Jia R, Xu X, Wang H, Hu J, et al. Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101. Invest Ophthalmol Vis Sci 2010; 51:2626 - 35; http://dx.doi.org/10.1167/iovs.09-3516; PMID: 20007825
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang H, Zhang J, Qian G, Niu B, Fan X, et al. Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors. Mol Ther 2009; 17:57 - 64; http://dx.doi.org/10.1038/mt.2008.236; PMID: 19018252
   PubMed Web of Science ®Google Scholar
• Jiang G, Liu YQ, Wei ZP, Pei DS, Mao LJ, Zheng JN. Enhanced antitumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis. Cancer Lett 2010; 294:220 - 8; http://dx.doi.org/10.1016/j.canlet.2010.02.003; PMID: 20189296
   PubMed Web of Science ®Google Scholar
• Pan Q, Liu B, Liu J, Cai R, Wang Y, Qian C. Synergistic induction of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying TRAIL. Mol Cell Biochem 2007; 304:315 - 23; http://dx.doi.org/10.1007/s11010-007-9514-6; PMID: 17577631
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qin X, Zhang Y, Zhao L, Wang Y, Liu X, et al. Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer. J Cancer Res Clin Oncol 2008; 134:219 - 26; http://dx.doi.org/10.1007/s00432-007-0273-2; PMID: 17632733
   PubMed Web of Science ®Google Scholar
• Ingemarsdotter CK, Baird SK, Connell CM, Oberg D, Hallden G, McNeish IA. Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer. Oncogene 2010; 29:6051 - 63; http://dx.doi.org/10.1038/onc.2010.335; PMID: 20729921
   PubMed Web of Science ®Google Scholar
• Ottolino-Perry K, Diallo JS, Lichty BD, Bell JC, McCart JA. Intelligent design: combination therapy with oncolytic viruses. Mol Ther 2010; 18:251 - 63; http://dx.doi.org/10.1038/mt.2009.283; PMID: 20029399
   PubMed Web of Science ®Google Scholar
• Triozzi PL, Eng C, Singh AD. Targeted therapy for uveal melanoma. Cancer Treat Rev 2008; 34:247 - 58; http://dx.doi.org/10.1016/j.ctrv.2007.12.002; PMID: 18226859
   PubMed Web of Science ®Google Scholar
• Lu W, Zheng S, Li XF, Huang JJ, Zheng X, Li Z. Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trial. World J Gastroenterol 2004; 10:3634 - 8; PMID: 15534920
   PubMed Web of Science ®Google Scholar
• Bergelson JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, Finberg RW. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 1997; 175:697 - 700; http://dx.doi.org/10.1093/infdis/175.3.697; PMID: 9041347
   PubMed Web of Science ®Google Scholar
• Wang Y, Gangeswaran R, Zhao X, Wang P, Tysome J, Bhakta V, et al. CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells. J Clin Invest 2009; 119:1604 - 15; http://dx.doi.org/10.1172/JCI37905; PMID: 19411761
   PubMed Web of Science ®Google Scholar
• Tyler MA, Ulasov IV, Lesniak MS. Cancer cell death by design: apoptosis, autophagy and glioma virotherapy. Autophagy 2009; 5:856 - 7; PMID: 19430207
   PubMed Web of Science ®Google Scholar
• Sanada M, Hidaka M, Takagi Y, Takano TY, Nakatsu Y, Tsuzuki T, et al. Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis. Carcinogenesis 2007; 28:2657 - 63; http://dx.doi.org/10.1093/carcin/bgm188; PMID: 17881774
   PubMed Web of Science ®Google Scholar
• Cherubini G, Petouchoff T, Grossi M, Piersanti S, Cundari E, Saggio I. E1B55K-deleted adenovirus (ONYX-015) overrides G1/S and G2/M checkpoints and causes mitotic catastrophe and endoreduplication in p53-proficient normal cells. Cell Cycle 2006; 5:2244 - 52; http://dx.doi.org/10.4161/cc.5.19.3263; PMID: 16969092
   PubMed Web of Science ®Google Scholar
• Seidman MA, Hogan SM, Wendland RL, Worgall S, Crystal RG, Leopold PL. Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle. Mol Ther 2001; 4:13 - 21; http://dx.doi.org/10.1006/mthe.2001.0414; PMID: 11472101
   PubMed Web of Science ®Google Scholar
• Hemminki A, Kanerva A, Liu B, Wang M, Alvarez RD, Siegal GP, et al. Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression. Cancer Res 2003; 63:847 - 53; PMID: 12591736
   PubMed Web of Science ®Google Scholar
• Bernt KM, Steinwaerder DS, Ni S, Li ZY, Roffler SR, Lieber A. Enzyme-activated prodrug therapy enhances tumor-specific replication of adenovirus vectors. Cancer Res 2002; 62:6089 - 98; PMID: 12414633
   PubMed Web of Science ®Google Scholar
• Alonso MM, Gomez-Manzano C, Bekele BN, Yung WK, Fueyo J. Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. Cancer Res 2007; 67:11499 - 504; http://dx.doi.org/10.1158/0008-5472.CAN-07-5312; PMID: 18089777
   PubMed Web of Science ®Google Scholar
• Jiang G, Xin Y, Zheng JN, Liu YQ. Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach. Int J Cancer 2011; 129:263 - 74; http://dx.doi.org/10.1002/ijc.25948; PMID: 21509783
   PubMed Web of Science ®Google Scholar
• Thomas MA, Spencer JF, Toth K, Sagartz JE, Phillips NJ, Wold WS. Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model. Mol Ther 2008; 16:1665 - 73; http://dx.doi.org/10.1038/mt.2008.162; PMID: 18665155
   PubMed Web of Science ®Google Scholar
• Niederkorn JY. Mechanisms of immune privilege in the eye and hair follicle. J Investig Dermatol Symp Proc 2003; 8:168 - 72; http://dx.doi.org/10.1046/j.1087-0024.2003.00803.x; PMID: 14582667
   PubMed Web of Science ®Google Scholar
• Niederkorn JY. Immune escape mechanisms of intraocular tumors. Prog Retin Eye Res 2009; 28:329 - 47; http://dx.doi.org/10.1016/j.preteyeres.2009.06.002; PMID: 19563908
   PubMed Web of Science ®Google Scholar
• Jia R, Jiao Z, Xu X, Wang J, Zhou Y, Song X, et al. Functional significance of B7-H1 expressed by human uveal melanoma cells. Mol Med Rep 2011; 4:163 - 5; PMID: 21461580
   PubMed Web of Science ®Google Scholar